Literature DB >> 9155588

DPC4 gene mutation in colitis associated neoplasia.

A T Hoque1, S A Hahn, M Schutte, S E Kern.   

Abstract

BACKGROUND: Colitis associated dysplasia and cancer often have deletions involving the long arm of chromosome 18q, suggesting the location of a tumour suppressor gene critical for their tumorigenesis. The DPC4 gene, which is genetically inactivated in pancreatic and other cancers, has recently been described. AIM: Because DPC4 is located at 18q21.1, the hypothesis that it could be a mutated tumour suppressor gene in colitis associated neoplasms was tested. PATIENTS: Advanced neoplastic lesions from six patients having chronic colitis were analysed for DPC4.
METHODS: Individual exons of DPC4 were amplified by the polymerase chain reaction (PCR) and sequenced from genomic DNA of tissue specimens dissected by cryostat.
RESULTS: DPC4 was found to have biallelic inactivation in one of three neoplasms shown to have allelic loss of 18q. The mutation had been acquired somatically in a plaque of high grade dysplasia. The mutation created a non-sense codon, which would cause premature termination of protein translation.
CONCLUSION: The DPC4 gene is a target of 18q LOH events in colitis associated neoplasia.

Entities:  

Mesh:

Year:  1997        PMID: 9155588      PMCID: PMC1027020          DOI: 10.1136/gut.40.1.120

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  13 in total

1.  Activation of c-Ki-ras in human gastrointestinal dysplasias determined by direct sequencing of polymerase chain reaction products.

Authors:  S J Meltzer; S M Mane; P K Wood; J H Resau; C Newkirk; J A Terzakis; B I Korelitz; W M Weinstein; S W Needleman
Journal:  Cancer Res       Date:  1990-06-15       Impact factor: 12.701

2.  Molecular genetic profiles of colitis-associated neoplasms.

Authors:  S E Kern; M Redston; A B Seymour; C Caldas; S M Powell; S Kornacki; K W Kinzler
Journal:  Gastroenterology       Date:  1994-08       Impact factor: 22.682

3.  c-Ki-ras mutations in dysplastic fields and cancers in ulcerative colitis.

Authors:  J Chen; C Compton; E Cheng; F Fromowitz; M V Viola
Journal:  Gastroenterology       Date:  1992-06       Impact factor: 22.682

4.  Neoplastic progression in ulcerative colitis: histology, DNA content, and loss of a p53 allele.

Authors:  G C Burmer; P S Rabinovitch; R C Haggitt; D A Crispin; T A Brentnall; V R Kolli; A C Stevens; C E Rubin
Journal:  Gastroenterology       Date:  1992-11       Impact factor: 22.682

5.  Allelotype of pancreatic adenocarcinoma using xenograft enrichment.

Authors:  S A Hahn; A B Seymour; A T Hoque; M Schutte; L T da Costa; M S Redston; C Caldas; C L Weinstein; A Fischer; C J Yeo
Journal:  Cancer Res       Date:  1995-10-15       Impact factor: 12.701

6.  Identification of a chromosome 18q gene that is altered in colorectal cancers.

Authors:  E R Fearon; K R Cho; J M Nigro; S E Kern; J W Simons; J M Ruppert; S R Hamilton; A C Preisinger; G Thomas; K W Kinzler
Journal:  Science       Date:  1990-01-05       Impact factor: 47.728

7.  DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1.

Authors:  S A Hahn; M Schutte; A T Hoque; C A Moskaluk; L T da Costa; E Rozenblum; C L Weinstein; A Fischer; C J Yeo; R H Hruban; S E Kern
Journal:  Science       Date:  1996-01-19       Impact factor: 47.728

8.  Common occurrence of APC and K-ras gene mutations in the spectrum of colitis-associated neoplasias.

Authors:  M S Redston; N Papadopoulos; C Caldas; K W Kinzler; S E Kern
Journal:  Gastroenterology       Date:  1995-02       Impact factor: 22.682

9.  Molecular diagnosis of familial adenomatous polyposis.

Authors:  S M Powell; G M Petersen; A J Krush; S Booker; J Jen; F M Giardiello; S R Hamilton; B Vogelstein; K W Kinzler
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245

10.  p53 point mutations in dysplastic and cancerous ulcerative colitis lesions.

Authors:  J Yin; N Harpaz; Y Tong; Y Huang; J Laurin; B D Greenwald; M Hontanosas; C Newkirk; S J Meltzer
Journal:  Gastroenterology       Date:  1993-06       Impact factor: 22.682

View more
  12 in total

1.  Loss of Dpc4 expression in colonic adenocarcinomas correlates with the presence of metastatic disease.

Authors:  A Maitra; K Molberg; J Albores-Saavedra; G Lindberg
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

Review 2.  Inflammatory bowel disease: the problems of dysplasia and surveillance.

Authors:  P J Mitchell; E Salmo; N Y Haboubi
Journal:  Tech Coloproctol       Date:  2007-11-30       Impact factor: 3.781

Review 3.  Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells.

Authors:  Ugo Testa; Elvira Pelosi; Germana Castelli
Journal:  Med Sci (Basel)       Date:  2018-04-13

Review 4.  Inflammatory bowel disease-associated colorectal cancer: proctocolectomy and mucosectomy do not necessarily eliminate pouch-related cancer incidences.

Authors:  Amosy E M'Koma; Harold L Moses; Samuel E Adunyah
Journal:  Int J Colorectal Dis       Date:  2011-02-11       Impact factor: 2.571

5.  Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas : a new marker of DPC4 inactivation.

Authors:  R E Wilentz; G H Su; J L Dai; A B Sparks; P Argani; T A Sohn; C J Yeo; S E Kern; R H Hruban
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

6.  Analysis of SMAD4/DPC4 gene alterations in multiploid colorectal carcinomas.

Authors:  Tatsuya Ando; Tamotsu Sugai; Wataru Habano; Yu-Fei Jiao; Kazuyuki Suzuki
Journal:  J Gastroenterol       Date:  2005-07       Impact factor: 7.527

7.  Microsatellite instability is uncommon in intestinal mucosa of patients with Crohn's disease.

Authors:  A Noffsinger; S Kretschmer; J Belli; F Fogt; C Fenoglio-Preiser
Journal:  Dig Dis Sci       Date:  2000-02       Impact factor: 3.199

8.  Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas.

Authors:  C A Iacobuzio-Donahue; D S Klimstra; N V Adsay; R E Wilentz; P Argani; T A Sohn; C J Yeo; J L Cameron; S E Kern; R H Hruban
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

Review 9.  Abrogation of transforming growth factor-beta signaling in pancreatic cancer.

Authors:  Xia Lin; Xin-Hua Feng
Journal:  World J Surg       Date:  2005-03       Impact factor: 3.352

10.  G1 cell cycle arrest and apoptosis induction by nuclear Smad4/Dpc4: phenotypes reversed by a tumorigenic mutation.

Authors:  J L Dai; R K Bansal; S E Kern
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.